High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome

Archives of Dermatology

Volumn 146, Issue 10, 2010, Pages 1105-1110

  Tang, Jean Y ^a   Wu, Angela ^c   Linos, Eleni ^a   Parimi, Neeta ^d   Lee, Wayne ^c   Aszterbaum, Michelle ^c   Asgari, Maryam M ^e   Bickers, David R ^b   Epstein Jr , Ervin H ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGED; AMBULATORY CARE; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BLOOD SAMPLING; CANCER RISK; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC PREDISPOSITION; HUMAN; MALE; MULTIPLE REGRESSION; OBESITY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SELF REPORT; STATISTICAL SIGNIFICANCE; SUMMER; VITAMIN D DEFICIENCY; WINTER; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; SKIN TUMOR;

ADULT; BASAL CELL NEVUS SYNDROME; COHORT STUDIES; FEMALE; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77958175620     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.247     Document Type: Article

References (35)

1. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-2838.
2. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med. 2009;169(6):551-561.
3. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009;19(2):84-88.
4. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167(11):1159-1165. (Pubitemid 46919818)
5. Melamed ML, Michos ED, Post W, Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-1637.
6. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88(2):558S-564S.
7. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
8. Robinson JK. Sun exposure, sun protection, and vitamin D. JAMA. 2005;294(12):1541-1543.
9. Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006;54(2):301-317. (Pubitemid 43144400)
10. American Academy of Dermatology. Position statement on vitamin D. http://www.aad.org/forms/policies/Uploads/PS/AAD-PS-Vitamin-D.pdf. Accessed December 2008.
11. Querings K, Reichrath J. A plea for the analysis of vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS). Cancer Causes Control. 2004;15(2):219. (Pubitemid 38445369)
12. Sollitto RB, Kraemer KH, DiGiovanna JJ. Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J Am Acad Dermatol. 1997;37(6):942-947.
13. McCombie AMR, Mason RS, Damian DL. Vitamin D deficiency in Sydney skin cancer patients. Med J Aust. 2009;190(2):102.
14. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69(3):299-308. (Pubitemid 27154674)
15. Epstein EH, Shepard JA, Flotte TJ. Case records of the Massachusetts General Hospital: case 3-2008: an 80-year-old woman with cutaneous basal-cell carcinomas and cysts of the jaws. N Engl J Med. 2008;358(4):393-401.
16. Epstein E. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8(10):743-754.
17. +/- humans and mice. Cancer Prev Res (Phila Pa). 2010;3(1):25-34.
18. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes; Food and Nutrition Board; Institute of Medicine. Vitamin D. In: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1999.
19. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem. 2008;45(pt 2):153-159. (Pubitemid 351724586)
20. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes [published corrections appear in Am J Clin Nutr. 2006;84(5):1253 and 2007;86(3):809]. Am J Clin Nutr. 2006;84(1):18-28.
21. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88(6):1519-1527.
22. Centers for Disease Control and Prevention, National Center for Health Statistics. Unweighted response rates for NHANES 2003-2004 by gender and age. http://www.cdc.gov/nchs/data/nhanes/rrt0304mf.pdf. Accessed August 2009.
23. Kimball AB, Ehrlich A, Lawrence RC, Moshell AN, Turner ML. Validating standardized acquisition of digital dermatologic images for use in the National Health and Nutrition Examination Survey. Arch Dermatol. 2006;142(1):110-112.
24. Ersfeld DL, Rao DS, Body J-J, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer. Clin Biochem. 2004;37(10):867-874.
25. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone. 2002;30(5):771-777. (Pubitemid 34468001)
26. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626-632.
27. Glass D, Lens M, Swaminathan R, Spector TD, Bataille V. Pigmentation and vitamin D metabolism in Caucasians: low vitamin D serum levels in fair skin types in the UK. PLoS One. 2009;4(8):e6477. doi:10.1371/journal.pone.0006477.
28. Orwoll E, Nielson CM, Marshall LM, et al; Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab. 2009;94(4):1214-1222.
29. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-693.
30. Mundy GR, Yang X. Hedgehog coordination of postnatal osteoclast and osteoblast activities. Dev Cell. 2008;14(5):637-638. (Pubitemid 351622623)
31. Armas LA, Dowell S, Akhter M, et al. Ultraviolet-B radiation increases serum 25- hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol. 2007;57(4):588-593.
32. Malvy DJ-M, Guinot C, Preziosi P, et al. Relationship between vitamin D status and skin phototype in general adult population. Photochem Photobiol. 2000;71(4):466-469.
33. Vieth R. Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol. 2004;89-90(1-5):575-579.
34. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-210.
35. 3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73(2):288-294.